In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.
Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."
Recent comments
9 weeks 23 hours ago
10 weeks 8 hours ago
11 weeks 4 days ago
12 weeks 23 hours ago
12 weeks 3 days ago
16 weeks 6 days ago
17 weeks 6 days ago
17 weeks 6 days ago
19 weeks 1 day ago
24 weeks 3 days ago